Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 511

Similar articles for PubMed (Select 16840949)

1.

[Prevention of major ischemic events in lower limb arterial disease: does aspirin play a role?].

Lechat P, Priollet P.

J Mal Vasc. 2006 Jul;31(3):129-34. French.

PMID:
16840949
2.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

5.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Antithrombotic Trialists' Collaboration.

BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141.

6.

Role of antiplatelet drugs in the prevention of cardiovascular events.

Tendera M, Wojakowski W.

Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.

PMID:
14592562
8.
9.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

10.

The platelet in diabetes: focus on prevention of ischemic events.

Colwell JA, Nesto RW.

Diabetes Care. 2003 Jul;26(7):2181-8. Review.

PMID:
12832332
11.

[The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].

Drouet L, Bal dit Sollier C, Henry P.

Drugs. 2010 Nov 1;70 Suppl 1:9-14. doi: 10.2165/00000005-000000000-00000. Review. Japanese.

PMID:
20977287
12.

Antiplatelet therapy in peripheral arterial disease.

Aronow WS.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep;4(3):265-7. Review.

PMID:
15379619
13.

Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Stroke. 2003 Aug;34(8):2072-80. Epub 2003 Jul 10. Review.

14.

Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.

Helton TJ, Bavry AA, Kumbhani DJ, Duggal S, Roukoz H, Bhatt DL.

Am J Cardiovasc Drugs. 2007;7(4):289-97.

PMID:
17696569
15.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
16.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315
17.

Aspirin withdrawal and acute lower limb ischemia.

Albaladejo P, Geeraerts T, Francis F, Castier Y, Les├Ęche G, Marty J.

Anesth Analg. 2004 Aug;99(2):440-3, table of contents.

PMID:
15271721
18.

Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.

Colwell JA.

Am J Cardiovasc Drugs. 2004;4(2):87-106. Review.

PMID:
15049721
20.

[Antiplatelet therapy in patients with peripheral arterial disease (PAD)].

Diehm C, Lawall H, Huber R.

Med Klin (Munich). 2004 Aug 15;99 Suppl 1:14-20. German.

PMID:
15487853
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk